Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of Monopoly Game on Subtle Behaviors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02729389
Recruitment Status : Completed
First Posted : April 6, 2016
Last Update Posted : September 17, 2019
Sponsor:
Collaborators:
University of Alabama at Birmingham
Brown University
Information provided by (Responsible Party):
University of Florida

Brief Summary:
The purpose of this research study is to investigate how social standing in a game of Monopoly may influence behavior.

Condition or disease Intervention/treatment Phase
Psychosocial Influence on Cardiovascular Disease Cardiovascular Disease Behavioral: High Social Status Condition Behavioral: Low Social Status Condition Not Applicable

Detailed Description:
Participants will be asked to fill out questionnaires/surveys and health measures will be collected throughout the study visit. These health measures will include: blood pressure, heart rate, height/weight, waist circumference, percent body fat, resting metabolic rate, and salivary cortisol. Breakfast will be provided and then a 40-minute game of Monopoly™ will be played, and lunch will be provided after the game. Participants will be given an accelerometer to measure movements, and a food diary to be used for a 24-hour period. Once the 24-hour monitoring period has been completed, the participants will be finished with the study activities. The accelerometer and food diary will be returned by either bringing them to the investigators or mailing the items back to the investigators.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 133 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: The Effects of Experimentally Manipulated Social Status on Energy Balance in Youth: A Randomized Controlled Trial
Actual Study Start Date : June 2016
Actual Primary Completion Date : July 7, 2018
Actual Study Completion Date : July 7, 2018

Arm Intervention/treatment
Experimental: High Social Status Condition
Participants will be provided with a high degree of privilege in a game of Monopoly.
Behavioral: High Social Status Condition
Participants will be provided with a high degree of privilege in a game of Monopoly.

Experimental: Low Social Status Condition
Participants will be provided with a low degree of privilege in a game of Monopoly.
Behavioral: Low Social Status Condition
Participants will be provided with a low degree of privilege in a game of Monopoly.




Primary Outcome Measures :
  1. Energy balance between the groups at hour 4 and over 24 hours [ Time Frame: Hour 4, After 24 Hours ]
    The investigators will assess energy balance using accelerometry, consumption data and resting metabolic rate.


Secondary Outcome Measures :
  1. Change in blood pressure between the groups at hours 0, 1, 3, 4 [ Time Frame: Hours 0, 1, 3, 4 ]
    Systolic and diastolic blood pressure will be assessed.

  2. Change in heart rate between the groups at hours 0, 1, 3, 4 [ Time Frame: Hours 0, 1, 3, 4 ]
    Heart rate will be captured using a heart rate monitor.

  3. Change in salivary cortisol between the groups at hours 1, 3 [ Time Frame: Hours 1, 3 ]
    Salivary cortisol will be collected and tested to determine objective stress levels.

  4. Change in Visual Analog Scales (VAS) between the groups at hours 0, 1, 3, 4 [ Time Frame: Hours 0, 1, 3, 4 ]
    Scores are from 0 - 100, 0 generally meaning least and 100 generally meaning most.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Hispanic American adolescents born in the United States
  • Have played Monopoly before

Exclusion Criteria:

  • Clinical depression
  • A diagnosis of cardiovascular disease (active or within the past 6 months), cancer (active or within the past 2 years, except non-melanoma skin cancer), diabetes (type 1 or 2), active or chronic infections, gastrointestinal disease, active kidney disease, lung disease, uncontrolled psychiatric disease
  • An eating disorder or severely restricted diet
  • Use of tobacco products
  • Substance abuse disorder
  • Take any medications known to affect appetite or body composition
  • Participation in any weight-reduction programs, weight-loss diets, or other special diets within the previous 3 months
  • Experience of weight loss or gain of 10 pounds or more of body weight in the past 6 months for any reason except post-partum weight loss
  • Current/Anticipation of pregnancy during study
  • Currently nursing or within 6 weeks of having completed nursing

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02729389


Locations
Layout table for location information
United States, Florida
University of Florida Clinical Translational Science Institute
Gainesville, Florida, United States, 32610
Sponsors and Collaborators
University of Florida
University of Alabama at Birmingham
Brown University
Investigators
Layout table for investigator information
Principal Investigator: Michelle I Cardel, PhD, RD University of Florida
Layout table for additonal information
Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT02729389    
Other Study ID Numbers: IRB201600361
First Posted: April 6, 2016    Key Record Dates
Last Update Posted: September 17, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by University of Florida:
Social Status
Hispanics
Energy Balance
Stress
Additional relevant MeSH terms:
Layout table for MeSH terms
Cardiovascular Diseases